Home > About Japan Comprehensive Cancer Network, Breast (JCCNB) > 2011FY


NCCN/JCCNB Seminar (arrangement)
(Personalized medicine in the treatment of DCIS - Current status and future prospects -)

Date April 15, 2012
Venue Tokyo International Forum


JCCNB Seminar

The 11st JCCNB seminar (Jun 11) 
Place: Teusler Hall / 36 Attendants
Report on ASCO Annual Meeting

The 12th JCCNB seminar (Sep 17)
Place: Teusler Hall / 26 Attendants
Report on ASCO Breast Cancer Symposium

The 13th JCCNB seminar (Dec 17)
Place: Teusler Hall / 33 Attendants
Report on the San Antonio Breast Cancer Symposium


Translation of Guideline

Guidelines for Treatment of Breast Cancer

  • Breast Cancer
  • Breast Cancer Risk Reduction
  • Breast Cancer Screening and Diagnosis
  • Genetics/Familial High-Risk Assessment:Breast and Ovarian

Guidelines for Supportive Care

  • Distress Management
  • Palliative Care
  • Cancer-Related Fatigue
  • Adult Cancer Pain
  • Antiemesis
  • Cancer-and Chemotherapy-Induced Anemia
  • Prevention and Treatment of Cancer-Related infections
  • Myeloid Growth Factors
  • Senior Adult Oncology
  • Venous Thromboembolic Disease



The results of questionnaire survey on circumstances where DCIS is diagnosed (2010.1-12)

Shipment:  621 establishments
Number of respondents: 292 establishments
Response rate: 47.0 %

Valid Responses: 238 establishments
(Number of cases: 30443 cases)
(Number of DCIS: 4383 cases)
Response rate: 38.0 %